Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Chronic myeloid leukemia | 106 | 16 | |
Gastrointestinal stromal tumors | 30 | 5 | |
Acute lymphocytic leukemia | 5 | 0 | |
Dermatofibrosarcoma protuberans | 3 | 0 | |
Mast cell activation syndrome | 2 | 1 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Diarrhea | 6 | |
Nausea | 3 | |
Elevated liver enzymes | 2 | |
Fatigue | 2 | |
Fluid retention (edema) | 2 | |
Rashes (redness, swelling) | 2 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 3 | |
Moderate | 6 | |
Mild | 12 | |
None | 2 |